Citi keeps a Buy rating on Celldex (CLDX) with a $70 price target after after Jasper Therapeutics (JSPR) reported preliminary data from its ...

Updating peak systemic mastocytosis franchise revenue opportunity to $4 billion, catalyzed by strong AYVAKIT® (avapritin ...

RBC Capital analyst Gregory Renza lowered the firm’s price target on Jasper Therapeutics (JSPR) to $48 from $68 and keeps an Outperform rating ...

The mainstay of treatment for urticaria is oral ... especially in aspirin-sensitive urticaria. Nifedipine has a small effect in chronic urticaria, and is often used for patients with concomitant ...

NDAQ:KYMR) Kymera Therapeutics Outlines Key 2025 Objectives and Strategy to Advance Industry Leading Portfolio of Oral ...

SOUTH SAN FRANCISCO, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company ...

As many as nine in ten people - about four million of us - who believe they're allergic to penicillin are not, according to ...

The total market size of eosinophilic esophagitis in 2023 was approximately USD 1.80 trillion in the 7MM, which is expected to grow during the forecast period (2020-2034). Among EU4 and the UK, ...

Image Source: Zacks Investment Research Blueprint is conducting an early-stage study of BLU-808 to assess its unique potency ...

Bumps on the scalp can occur with trapped hair follicles or acne, but they can also be an indicator of another health condition. Bumps on your scalp can be a symptom of several different health ...

If you’re prone to hives, ask your doctor if you should carry a rapid-injection form of epinephrine in case you develop anaphylaxis. And if you have chronic hives that just don’t respond to milder ...

Exceeds the Upper End of Guidance Range for Full-Year 2024 with Unaudited Global Revenues of Approximately $363.7 Million-- --2025 Global ARIKAYCE Revenues Expected to be Between $405 Million ...